Value-Based Cardiology


This week in managed care the top stories include pivotal results from the SPRINT study on blood pressure, an analysis on how states successfully enrolled consumers in the insurance marketplace, and experts discuss value-based care.
Some takeaways from the most important blood pressure study in 40 years.
New results don't automatically change guidelines for systolic blood pressure, as an editorial in the New England Journal of Medicine notes.
Historically cancer survivorship programs have not emphasized cardiac follow-up and there is not a lot of long-term data on cardiac toxicity in patients who received certain drugs, but that is changing as patients live longer and fuller lives after treatment, explained Crystal S. Denlinger, MD, from the Fox Chase Cancer Center in Philadelphia.
Results show that bleeding was the most common reason patients stopped taking the drug in this study of long-term tolerability.


July 25-27, 2015
Vancouver, BC, Canada
August 14-16, 2015
Mackinac Island,MI
Diabetes Compendium
Oncology Compendium